Mushrooms: Importance, Types, Production and Economics
Abstract
Mushrooms represent an economically and biologically critical group of organisms within the kingdom Fungi, which comprises over 150,000 estimated species. Of these, approximately 14,000 to 22,000 produce macroscopic fruiting bodies. This review synthesizes current scientific literature regarding the nutritional, medicinal, ecological and industrial significance of mushrooms. We provide a taxonomic framework of major cultivated and wild species, detail global production systems and substrate biotechnology and analyse contemporary market economics. The global mushroom market was valued at roughly USD 33.2 billion in 2020 and is projected to exceed USD 86 billion by 2030, driven by a 9.5-10.8% compound annual growth rate (CAGR). With China contributing approximately 73% of the 10.5 million metric tonnes produced globally in 2021, the industry is scaling rapidly. High in protein (10-38% dry weight), immunomodulatory β-glucans and vital metabolites, mushrooms are critical to human health and nutrition. Furthermore, their ecological role as decomposers and their emerging industrial applications in mycoproteins and biodegradable packaging underscore their expanding value. This review highlights the necessity for further research, policy support and collaboration to maximize the potential of fungi in the circular bioeconomy.
Full Text
Tables and figures are in the full-text PDF.
Introduction
The kingdom Fungi is one of the most ecologically vital and taxonomically diverse groups of life on Earth, containing an estimated 1.5 to 5.1 million species (Hawksworth and Lücking, 2017) [9] . Macrofungi, which are defined as organisms that yield visible fruiting bodies (sporocarps), comprise roughly 14,000 to 22,000 described species (Kirk et al., 2008) [15] . Within this group, approximately 2,000 are identified as edible and nearly 700 are recognized for their pharmacological efficacy (Chang and Miles, 2004) [2] . The term "mushroom" commonly designates the sporocarps of macrofungi belonging to the phyla Basidiomycota and Ascomycota, including both industrially cultivated saprotrophic species and wild ectomycorrhizal species. Human utilization of mushrooms is deeply rooted in history, with archaeological findings indicating consumption in Europe and Asia dating back at least 10,000 years. Historical Chinese texts from 206 BCE mention Ganoderma lucidum (Lingzhi) as a highly prized medicinal remedy (Wasser, 2002) [29] . The industrial cultivation era began in France around 1707 with the deliberate farming of Agaricus bisporus (button mushrooms) on horse manure beds. By the 20th century, advancements in fungal biology, substrate decomposition and environmental controls established the foundation for the modern global industry. Today, mushroom science is driven by multidisciplinary applications:
• Nutrition: They provide umami-rich, high-protein, low-fat sustenance with a significantly lower environmental footprint than animal proteins. • Medicine: Pharmaceutical applications, such as the immunomodulatory polysaccharopeptides lentinan, PSK and PSP, have been approved for cancer therapies in Asia. • Ecology: Mycorrhizal networks facilitate critical nutrient exchanges across forest ecosystems.
• Materials Science: Biodegradable mycelium composites are replacing synthetic materials like polystyrene and leather.
Importance Of Mushrooms 2.1 Nutritional Significance
Mushrooms effectively bridge the dietary gap between plant and animal-derived foods. While species-specific, their macronutrient profile generally features high protein content (10-38% dry weight), minimal lipids (1-8% dry weight) and moderate carbohydrates primarily consisting of chitin, glycogen, trehalose and β-glucans (Mau et al., 2001; Cheung, 2010) [18,5] . The protein quality in species like Pleurotus ostreatus and Lentinula edodes is comparable to egg whites, scoring 0.63-0.90 on the protein digestibility-corrected amino acid score (PDCAAS) (Kalač, 2009) and offering biologically significant concentrations of essential amino acids like lysine and leucine (Halliwell et al., 2018) [8] . Mushrooms also provide dietary fibers that support probiotic gut health and cholesterol reduction. Notably, mushrooms are rich in ergosterol, a precursor to vitamin D₂ (Ooi and Liu, 2000) [21] . Post-harvest UV-B exposure can fortify mushrooms to provide 100% of the recommended daily intake of vitamin D₂ per 100 g of fresh weight (Cheung, 2013) [4] . They are also a primary dietary source of ergothioneine, a crucial antioxidant with cytoprotective properties (Keegan et al., 2013) [13] . [18] , Cheung (2010) [5] and USDA FoodData Central (2023).
Nutrient
Medicinal and Pharmacological Properties
Mushrooms contain diverse bioactive compounds, including glycoproteins, terpenoids and sterols, which exhibit antitumor, antiviral, antidiabetic and neuroprotective properties (Mori et al., 2009) [19] .
• Immunomodulation and Anticancer Activity: Lentinan, a β-glucan from Lentinula edodes, is approved in Japan as an adjunct immunotherapy for gastric, colorectal and breast cancers, significantly improving patient survival rates. Similarly, PSK (Krestin) from Trametes versicolor is a leading cancer drug in Japan (Zhang et al., 2014) [31] . (2010) [3] .
Ecological Importance
Fungi drive global carbon cycles, responsible for about 85% of organic matter mineralisation in forest soils (Baldrian, 2017) [1] . Ligninolytic species secrete extracellular enzymes that depolymerise lignin, releasing carbon and forming vital soil organic carbon stocks (Schlesinger and Bernhardt, 2013) [25] . Ectomycorrhizal (ECM) fungi form mutualistic networks with approximately 8,000 plant species, exchanging essential nutrients for photosynthetic carbon, dramatically improving forest productivity (Klupp et al., 2015) [16] . Furthermore, fungi are highly effective in mycoremediation, utilizing their broad enzyme profiles to detoxify pollutants like heavy metals, diesel oil and microplastics (Rinaldi et al., 2008) [22] .
Industrial and Biotechnological Applications
Fungi are industrial powerhouses. For example, Aspergillus niger produces ~2 million metric tonnes of citric acid annually and white-rot basidiomycetes are evaluated for pretreating agricultural residues for bioethanol production (Smith and Read, 2008) [26] . Mycelium-based composites are emerging as a revolutionary materials sector. Grown on agricultural waste, these composites match the tensile strength of polystyrene but biodegrade entirely within 30-90 days (Holt et al., 2012) [10] . Fungal biomaterials are also being utilized in luxury fashion as a sustainable alternative to bovine leather.
Taxonomy and Major Cultivated Species 3.1 Taxonomic Framework
Macrofungi are predominantly classified into two phyla: Basidiomycota (~30,000 species) and Ascomycota (~65,000 species) (Olatunji et al., 2018) [20] . Agaricomycetes, a class within Basidiomycota, includes most gilled mushrooms and polypores, while Ascomycota includes morels and truffles.
Major Commercially Cultivated Species
Substrate Science and Biotechnology
Cultivation is fundamentally the bioconversion of lignocellulosic plant biomass into high-value protein. The optimal Carbon-to-Nitrogen (C: N) ratio for substrates is 20:1-40:1. Substrates undergo pasteurization, sterilization, or complex fermentation (composting) and are supplemented with agricultural by-products to modulate pH (6.0-7.5) and moisture (60-68%) (Khan et al., 2018) [14] .
Emerging biotechnologies include enzyme pre-treatments, cold pasteurization via alkaline lime treatments (reducing energy costs by 60-75%) and bio fermentation using suppressive Bacillus subtilis inoculants.
Spawn Production and Cultivation Infrastructure
Commercial spawn (mycelium) is propagated on sterilized grain or sawdust. High-tech farms utilize liquid fermentation spawn generated in bioreactors (50-1,000 L) for rapid, genetically homogenous colonization (Mane et al., 2007) [17] . Cultivation occurs in tightly controlled indoor environments dictating precise temperature (±0.5 °C), humidity and CO₂. Pests like sciarid flies and diseases such as Trichoderma aggressivum (green mould) are managed via strict Integrated Pest Management (IPM), including HEPA filtration, biological control agents and precise farm hygiene (Sánchez, 2010) [24] .
Economics Of The Global Mushroom Industry 5.1 Market Size and Growth
The industry is experiencing a massive boom due to health trends, urbanisation and clinical validations. In 2020, the edible mushroom segment was valued at USD 17.
Challenges And Future Perspectives
The mushroom sector faces pressing challenges, particularly the impacts of climate change on the fruiting patterns of wild ectomycorrhizal species and the soaring energy costs of indoor climate-controlled cultivation (Kauserud et al., 2012) [12] . Substrate competition is intensifying as bioenergy and animal feed sectors vie for the same agricultural residues. A transition to circular urban farming models utilizing municipal organic waste presents a viable solution.
Additionally, the standardization of bioactive content in dietary supplements remains a severe regulatory hurdle, necessitating precise HPLC quantification to prevent quality discrepancies. Future growth relies heavily on genomic frontiers, including CRISPR/Cas9 strain improvements for yield and stress tolerance and metagenomic discoveries from the rapidly expanding database of over 1,000 annotated fungal genomes.
Conclusion
Mushrooms represent a profound convergence of nutritional science, pharmacology, materials engineering and ecological sustainability. With a market poised to double within the decade, approaching a USD 100 billion valuation, they hold unique potential to address global challenges spanning food security, chronic disease and environmental degradation. To fully realize this potential, sustained international research, standardized regulatory frameworks and equitable technology transfer to developing economies are imperative. The kingdom Fungi is positioned to be a cornerstone of the 21st-century circular bioeconomy.
References
- Baldrian P. Forest microbiome: diversity, complexity and dynamics. FEMS Microbiol Rev. 2017;41(2):109130.
- Chang ST, Miles PG. Mushrooms: cultivation, nutritional value, medicinal effect and environmental impact. 2nd ed. Boca Raton (FL): CRC Press; 2004.
- Chen S, Li Z, Krochmal R, Abrazado M, Kim W, Cooper CB. Effect of Cs-4 (Cordyceps sinensis) on exercise performance in healthy older subjects. J Altern Complement Med. 2010;16(5):585-590.
- Cheung PCK. Mini-review on edible mushrooms as source of dietary fiber: preparation and health benefits. Food Sci Hum Wellness. 2013;2(3-4):162-166.
- Cheung PCK. The nutritional and health benefits of mushrooms. Nutr Bull. 2010;35(4):292-299.
- FAO. FAOSTAT: crops and livestock products. Rome: Food and Agriculture Organization of the United Nations; 2022.
- Grand View Research. Mushroom market size, share and trends analysis report by product, form, application, distribution channel, region and segment forecasts, 2022-2030. San Francisco (CA): Grand View Research; 2022.
- Halliwell B, Cheah IK, Tang RMY. Ergothioneine-a diet-derived antioxidant with therapeutic potential. FEBS Lett. 2018;592(20):3357-3366.
- Hawksworth DL, Lücking R. Fungal diversity revisited: 2.2 to 3.8 million species. Microbiol Spectr. 2017;5(4):FUNK-0052-2016.
- Holt GA, McIntyre G, Flagg D, Bayer E, Wanjura JD, Pelletier MG. Fungal mycelium and cotton plant materials in the manufacture of biodegradable molded packaging material. J Biobased Mater Bioenergy. 2012;6(4):431-439.
- Kalač P. Chemical composition and nutritional value of European species of wild growing mushrooms: a review. Food Chem. 2009;113(1):9-16.
- Kauserud H, Heegaard E, Semenov MA, Boddy L, Halvorsen R, Stige LC, Sparks TH, Gange AC, Stenseth NC. Climate change and spring-fruiting fungi. Proc R Soc B. 2012;277(1695):1169-1177.
- Keegan RJ, Lu Z, Bogusz JM, Williams JE, Holick MF. Photobiology of vitamin D in mushrooms and its bioavailability in humans. Dermatoendocrinol. 2013;5(1):165-176.
- Khan AA, Bhatt MK, Raghunath S, Prateeksha, Singh BN. Bacillus-based biological control agents against Trichoderma spp. in Agaricus bisporus cultivation. Biol Control. 2018;126:164-171.
- Kirk PM, Cannon PF, Minter DW, Stalpers JA, editors. Ainsworth and Bisby's dictionary of the fungi. 10th ed. Wallingford (UK): CAB International; 2008.
- Klupp NL, Chang D, Hawke F, Kiat H, Cao H, Grant SJ, Bensoussan A. Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors. Cochrane Database Syst Rev. 2015;2015(2):CD007259.
- Mane VP, Patil SS, Syed AA, Baig MMV. Bioconversion of low quality lignocellulosic agricultural waste into edible protein by Pleurotus sajor-caju. J Zhejiang Univ Sci B. 2007;8(10):745-751.
- Mau JL, Lin HC, Chen CC. Antioxidant properties of several medicinal mushrooms. J Agric Food Chem. 2001;50(21):6072-6077.
- Mori K, Inatomi S, Ouchi K, Azumi Y, Tuchida T. Improving effects of Hericium erinaceus on mild cognitive impairment: a double-blind placebocontrolled clinical trial. Phytother Res. 2009;23(3):367372.
- Olatunji OJ, Tang J, Tola A, Auberon F, Oluwaniyi O, Ouyang Z. The genus Cordyceps: an extensive review of its traditional uses, phytochemistry and pharmacology. Fitoterapia. 2018;129:293-316.
- Ooi VE, Liu F. Immunomodulation and anti-cancer activity of polysaccharide-protein complexes. Curr Med Chem. 2000;7(7):715-729.
- Rinaldi AC, Comandini O, Kuyper TW. Ectomycorrhizal fungal diversity: separating the wheat from the chaff. Fungal Divers. 2008;33:1-45.
- Royse DJ, Baars J, Tan Q. Current overview of mushroom production in the world. In: Zied DC, PardoGiménez A, editors. Edible and medicinal mushrooms: technology and applications. Hoboken (NJ): John Wiley & Sons; 2017. p. 5-13.
- Sánchez C. Cultivation of Pleurotus ostreatus and other edible mushrooms. Appl Microbiol Biotechnol. 2010;85(5):1321-1337.
- Schlesinger WH, Bernhardt ES. Biogeochemistry: an analysis of global change. 3rd ed. Waltham (MA): Academic Press; 2013.
- Smith SE, Read DJ. Mycorrhizal symbiosis. 3rd ed. London: Academic Press; 2008.
- Stamets P. Growing gourmet and medicinal mushrooms. 3rd ed. Berkeley (CA): Ten Speed Press; 2000.
- Wasser SP. Current findings, future trends and unsolved problems in studies of medicinal mushrooms. Appl Microbiol Biotechnol. 2011;89(5):1323-1332.
- Wasser SP. Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl Microbiol Biotechnol. 2002;60(3):258-274.
- WIPO. Mushroom and fungi-related patent landscape report. Geneva: World Intellectual Property Organization; 2023.
- Zhang M, Cui SW, Cheung PCK, Wang Q. Antitumor polysaccharides from mushrooms: a review on their isolation, structural characteristics and antitumor activities. Trends Food Sci Technol. 2014;18(1):4-19.
How this paper connects to the literature. Drag to explore, click any node to open that paper.
